Skip to main content
Erschienen in: Intensive Care Medicine 3/2019

12.03.2019 | What's New in Intensive Care

Top ten tips for the management of critically ill hematopoietic stem cell transplantation recipients

verfasst von: Etienne Lengliné, Adrien Mirouse, Elie Azoulay

Erschienen in: Intensive Care Medicine | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Excerpt

Hematopoietic stem cells are capable of self-renewal and have the outstanding property of giving rise to all blood and immune cells in a stable manner. Autologous and allogeneic therapeutic use of these cells has become a standard of care for various malignant and non-malignant hematological diseases. Both procedures are associated with a high level of medicalization, drug prescription, intra-hospital transfer, and ICU use. We sought to put forward ten important tips for the management of critically ill hematopoietic stem cell transplant (HSCT) recipients. …
Literatur
1.
Zurück zum Zitat Kerhuel L, Amorim S, Azoulay E, Thiéblemont C, Canet E (2015) Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma. Leuk Lymphoma 56:3090–3095CrossRef Kerhuel L, Amorim S, Azoulay E, Thiéblemont C, Canet E (2015) Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma. Leuk Lymphoma 56:3090–3095CrossRef
2.
Zurück zum Zitat Jantunen E et al (2006) Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients. Eur J Haematol 76:245–250CrossRef Jantunen E et al (2006) Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients. Eur J Haematol 76:245–250CrossRef
3.
Zurück zum Zitat Bayraktar UD et al (2013) Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol 31:4207–4214CrossRef Bayraktar UD et al (2013) Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol 31:4207–4214CrossRef
4.
Zurück zum Zitat Canet E et al (2014) Acute kidney injury in critically ill allo-HSCT recipients. Bone Marrow Transplant 49:1121CrossRef Canet E et al (2014) Acute kidney injury in critically ill allo-HSCT recipients. Bone Marrow Transplant 49:1121CrossRef
5.
Zurück zum Zitat Lengliné E et al (2015) Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 50:840–845CrossRef Lengliné E et al (2015) Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 50:840–845CrossRef
6.
Zurück zum Zitat Saillard C, Blaise D, Mokart D (2016) Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis. Bone Marrow Transplant 51:1050–1061CrossRef Saillard C, Blaise D, Mokart D (2016) Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis. Bone Marrow Transplant 51:1050–1061CrossRef
7.
Zurück zum Zitat Azoulay E et al (2015) Managing critically ill hematology patients: time to think differently. Blood Rev 29:359–367CrossRef Azoulay E et al (2015) Managing critically ill hematology patients: time to think differently. Blood Rev 29:359–367CrossRef
8.
Zurück zum Zitat Soares M et al (2016) Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care units. J Clin Oncol 34:3315–3324CrossRef Soares M et al (2016) Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care units. J Clin Oncol 34:3315–3324CrossRef
9.
Zurück zum Zitat Gooley TA et al (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363:2091–2101CrossRef Gooley TA et al (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363:2091–2101CrossRef
10.
Zurück zum Zitat Mokart D et al (2015) Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: outcomes of patients admitted to intensive care unit. J Crit Care 30:1107–1113CrossRef Mokart D et al (2015) Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: outcomes of patients admitted to intensive care unit. J Crit Care 30:1107–1113CrossRef
11.
Zurück zum Zitat Azoulay E et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 31:2810–2818CrossRef Azoulay E et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 31:2810–2818CrossRef
12.
Zurück zum Zitat Contejean A et al (2016) Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study. Ann Intensive Care 6:102CrossRef Contejean A et al (2016) Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study. Ann Intensive Care 6:102CrossRef
13.
Zurück zum Zitat Schnell D et al (2013) Clinical assessment for identifying causes of acute respiratory failure in cancer patients. Eur Respir J 42:435–443CrossRef Schnell D et al (2013) Clinical assessment for identifying causes of acute respiratory failure in cancer patients. Eur Respir J 42:435–443CrossRef
14.
Zurück zum Zitat Kontoyiannis DP et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50:1091–1100CrossRef Kontoyiannis DP et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50:1091–1100CrossRef
15.
Zurück zum Zitat Marr KA, Carter RA, Boeckh M, Martin P, Corey L (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100:4358–4366CrossRef Marr KA, Carter RA, Boeckh M, Martin P, Corey L (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100:4358–4366CrossRef
16.
Zurück zum Zitat Lueck C et al (2018) Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med 44:1483–1492CrossRef Lueck C et al (2018) Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med 44:1483–1492CrossRef
17.
Zurück zum Zitat Nakamura M et al (2018) Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation. Int J Hematol 108:622–629CrossRef Nakamura M et al (2018) Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation. Int J Hematol 108:622–629CrossRef
Metadaten
Titel
Top ten tips for the management of critically ill hematopoietic stem cell transplantation recipients
verfasst von
Etienne Lengliné
Adrien Mirouse
Elie Azoulay
Publikationsdatum
12.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 3/2019
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-019-05587-0

Weitere Artikel der Ausgabe 3/2019

Intensive Care Medicine 3/2019 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.